Elevance Health's stock up 5% after earnings beat estimates
Elevance Health Inc.'s stock (ELV) rose 5% in premarket trade Wednesday, after the health insurer's second-quarter earnings handily beat estimates. The company posted net income of $1.853 billion, or $7.79 a share, for the quarter, up from $1.637 billion, or $6.73 a share, in the year-earlier period. Adjusted per-share earnings came to $9.04, ahead of the $8.78 FactSet consensus. Revenue rose 12.7% to $43.672 billion from $38.632 billion, also ahead of the $41.636 billion FactSet consensus. "Given the strong performance in the first half of the year and momentum across Elevance Health, we now expect GAAP net income to be greater than $29.09 per share in 2023, and adjusted net income to be greater than $32.85 per share," the company said in a statement. The current FactSet consensus is for full-year EPS of $32.77. The company's benefit expense ratio was 86.4% in the quarter, down 70 basis points from the year-earlier period, mostly due to premium rate adjustments to more accurately reflect cost of care. Health insurers have seen their costs rise this year as seniors are catching up on hip and knee surgeries that were delayed by the COVID pandemic. Elevance's stock has fallen 13% in the year to date, while the S&P 500 has gained 18.6%.
-Ciara Linnane
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-19-23 0734ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening In the Markets This Week
-
How Anti-Obesity Drugs Are Innovating the Healthcare Market
-
Why Immigration Has Boosted Job Gains and the Economy
-
What to Invest in During High Inflation
-
Never Mind Market Efficiency: Are the Markets Sensible?
-
Starbucks Stock Could Use a Pick-Me-Up After Big Selloff; Is it a Buy?
-
5 Cheap Stocks to Buy From an Attractive Part of the Market
-
Markets Brief: All Eyes On Inflation
-
8 Stock Picks in the Apparel Industry
-
Baidu Earnings: Advertising Weakness Offset by Continued Growth In Cloud Business
-
Going Into Earnings, Is Target Stock a Buy, a Sell, or Fairly Valued?
-
Walmart Earnings: Low Prices and Strong Digital Presence Drive Market Share Gains
-
After Earnings and a Big Selloff, Is Shopify Stock a Buy, a Sell, or Fairly Valued?
-
Cisco Earnings: Positive Guidance and Splunk Inclusion Align With Our Long-Term Thesis
-
3 Warren Buffett Stocks to Buy After Berkshire Hathaway’s Just-Released 13F Filing
-
Going Into Earnings, Is Nvidia Stock a Buy, a Sell, or Fairly Valued?